Sanofi-Aventis Completes Acquisition of Australian Firm

Sanofi-Aventis (Paris) says it has completed the acquisition of Australian firm Symbion Consumer (Melbourne) for A$560 million ($479 million). Symbion Consumer manufactures and sells nutraceuticals (vitamins & mineral supplements) and over the counter brands in Australia and New Zealand. Symbion Consumer had revenues of about A$190 million in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers